Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1F. Hoffmann-La Roche Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The Generic Rx Session
Not Confirmed
arrow
arrow
The Generic Rx Session
Not Confirmed

ENTRECTINIB

NDC Package Code : 12806-0090

Start Marketing Date : 2024-07-03

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (20kg/20kg)

Marketing Category : BULK INGREDIENT

blank

Looking for 1108743-60-7 / Entrectinib API manufacturers, exporters & distributors?

Entrectinib manufacturers, exporters & distributors 1

25

PharmaCompass offers a list of Entrectinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Entrectinib manufacturer or Entrectinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Entrectinib manufacturer or Entrectinib supplier.

PharmaCompass also assists you with knowing the Entrectinib API Price utilized in the formulation of products. Entrectinib API Price is not always fixed or binding as the Entrectinib Price is obtained through a variety of data sources. The Entrectinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Entrectinib

Synonyms

1108743-60-7, Rxdx-101, Nms-e628, Rozlytrek, Entrectinib (rxdx-101), Entrectinib(rxdx-101)

Cas Number

1108743-60-7

Unique Ingredient Identifier (UNII)

L5ORF0AN1I

About Entrectinib

Entrectinib is an orally bioavailable inhibitor of the tyrosine kinases tropomyosin receptor kinases (Trk) A, B and C, C-ros oncogene 1 (ROS1) and anaplastic lymphoma kinase (ALK), with potential antineoplastic activity. Upon administration, entrectinib binds to and inhibits TrkA, TrkB, TrkC, ROS1 and ALK. Inhibition of these kinases may result in a disruption of TrkA-, TrkB-, TrkC-, ROS1-, and ALK-mediated signaling. This leads to an induction of apoptosis and an inhibition of tumor cell proliferation in tumor cells that express these kinases. TrkA, TrkB, TrkC, ROS1 and ALK are overexpressed in a variety of cancer cell types.

Entrectinib Manufacturers

A Entrectinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Entrectinib, including repackagers and relabelers. The FDA regulates Entrectinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Entrectinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Entrectinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Entrectinib Suppliers

A Entrectinib supplier is an individual or a company that provides Entrectinib active pharmaceutical ingredient (API) or Entrectinib finished formulations upon request. The Entrectinib suppliers may include Entrectinib API manufacturers, exporters, distributors and traders.

click here to find a list of Entrectinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Entrectinib NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Entrectinib as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Entrectinib API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Entrectinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Entrectinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Entrectinib NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Entrectinib suppliers with NDC on PharmaCompass.

Entrectinib Manufacturers | Traders | Suppliers

Entrectinib Manufacturers, Traders, Suppliers 1
83

We have 1 companies offering Entrectinib

Get in contact with the supplier of your choice:

  1. F. Hoffmann-La Roche
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.